Morphiex Biotherapeutics

Morphiex Biotherapeutics Morphiex is harnessing the power of the immune system to fight cancer by developing the only dual-functioning immune checkpoint inhibitor.

Morphiex is a biotechnology company harnessing the power of the immune system to fight cancer by developing the only dual-functioning immune checkpoint inhibitor. Our lead drug candidate, MBT-001, blocks both "don't eat me"​ and thrombospondin-1 (TSP-1) pathways of . This enables direct tumor cell killing mediated by T cells, Natural Killer cells, Neutrophils as well as Macrophages.

Address

75 Arlington St
Boston, MA

Website

Alerts

Be the first to know and let us send you an email when Morphiex Biotherapeutics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category